TISSUE REGENIX GROUP is a pioneering, international medical technology company, focusing on the development of regenerative products utilising our two platform technologies, dCELL®, addressing soft tissue needs, and BioRinseTM, providing inductive bone allografts.

We are helping to transform the treatment of patients in three key areas: BioSurgery, Orthopaedics & Dental and Cardiac.

Our Vision

To establish TRG as a leader in the science and innovation of regenerative medicine.

Transforming patient care and delivering favourable health economic outcomes.

Global Operations Infrastructure

Platform for international expansion

Current locations

Tissue Regenix, Leeds, UK

Cellright Technologies, San Antonio, Texas

GBM-V, Rostock, Germany

locations map

You may also be interested in